Description
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 3
Primary Industries
- Drugs
- Delivery
- Cancer
- Therapeutic
- Respiratory
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 298918
'Pulmatrix's iSPERSEâ„¢ platform has the ability to enhance the safety and efficacy profile of promising drug candidates. 'We applied the iSPERSEâ„¢ technology to RV1162/PUR1800, the lead in-licensed inhibitor and helped unlock its clinical potential by improving the product's profile from the original formulation.
Licensee gains an option to access a portfolio of narrow spectrum kinase inhibitors intended for development in lung cancer interception.
IPSCIO Record ID: 213679
Further, Licensor hereby grants to Licensee a non-exclusive, sub-licensable, licence under the Licensor IP to use the same with clinical comparator products and mono products or combination products solely for the purposes of the development of Products hereunder.
Licensor IP means
(a) any and all Intellectual Property owned or controlled by Licensor or its Affiliates at the Effective Date relating to the Licensor Technology and/or Formulation(s), including the Patents and such rights in the Licensor Data; and
(b) any improvements or developments thereto developed independently of this Agreement; and
(c) any improvements or developments thereto created or developed by or on behalf of Licensee during the course of this Agreement except to the extent such improvements or developments constitute Licensee IP.
Intellectual Property means patents, supplementary protection certificates, trademarks, service marks, registered designs, rights in designs, applications for any of the foregoing, trade or business names, copyrights, rights under licences and consents for any such thing and all rights or forms of protection of a similar nature or having equivalent or similar effect subsisting anywhere in the world.
Product means any product combining a Device with a Formulation.
Licensor Data means any data, reports or other documentation, including the data package for PUR0200, in Licensor’s possession or under its control as at the Effective Date.
Device means an inhaler device to be determined by Licensee.
Formulation means (a) any formulation of Tiotropium formulated using the Licensor Technology, including PUR0200 and/or (b) any formulation of [*****] formulated using the Licensor Technology.
“[*****]†means [*****] alone for monotherapy, and not in combination with any other active ingredient.
Licensee IP means any Intellectual Property
a) covering a Device and any formulation of drugs for a Device and owned or controlled by Licensee or its Affiliates as of the Effective Date (which for the avoidance of doubt shall exclude the Formulations and Licensor Technology);
b) any improvements or developments thereto developed independently of this Agreement;
c) any improvements or developments thereto created or developed by or on behalf of Licensee during the course of this Agreement; and
d) created or developed by or on behalf of either Licensee during the course of this Agreement relating to a Device, including without limitation any improvements thereto, and relating to the development, Manufacture and connectivity (for example, but without limitation, mHealth) thereof.
IPSCIO Record ID: 166969
